Exposure to methamphetamine during brain development impairs cognition in humans and rodents. In mice, these impairments are more severe in females than males. Genetic factors, such as apolipoprotein E genotype, may modulate the cognitive effects of methamphetamine. Methamphetamine-induced alterations in the brain acetylcholine system may contribute to the cognitive effects of methamphetamine and may also be modulated by apolipoprotein E isoform. We assessed the long-term effects of methamphetamine exposure during brain development on cognitive function and muscarinic acetylcholine receptors in mice, and whether apolipoprotein E isoform modulates these effects. Mice expressing human apolipoprotein E3 or E4 were exposed to methamphetamine (5 mg/kg) or saline once a day from postnatal days 11-20 and behaviorally tested in adulthood. Muscarinic acetylcholine receptor binding was measured in the hippocampus and cortex. Methamphetamine exposure impaired novel location recognition in female, but not male, mice. Methamphetamine-exposed male and female mice showed impaired novel object recognition and increased number of muscarinic acetylcholine receptors in the hippocampus. The cognitive and cholinergic effects of methamphetamine were similar in apolipoprotein E3 and E4 mice. Thus, the cholinergic system, but not apolipoprotein E isoform, might play an important role in the long-term methamphetamine-induced cognitive deficits in adulthood.
Introduction
The use of amphetamines, including methamphetamine (MA), during pregnancy has increased over the past two decades in the US (Terplan et al., 2009) . Exposure to MA during brain development increases the risk of birth defects (Forrester and Merz, 2007) and being born small according to gestational age (Smith et al., 2006) . MA exposure has also been shown to cause physiological and cognitive impairments in infants that persist into adolescence (Struthers and Hansen, 1992; Chang et al., 2004; Smith et al., 2008 ). Children exposed to MA in utero show reduced spatial memory (Acevedo et al., 2008a) , visual motor integration, attention, and verbal memory (Chang et al., 2004 (Chang et al., , 2009 .
Animal studies examining the effects of MA exposure during brain development mirror the findings in humans. Rodent hippocampal development occurs during the first 3 postnatal weeks and models human hippocampal development during the third trimester (Clancy et al., 2007a (Clancy et al., , 2007b Winzer-Serhan, 2008) . Wildtype (WT) rats and mice exposed to MA during postnatal hippocampal development show impaired spatial learning and memory (Vorhees et al., 2000 Williams et al., 2002 Williams et al., , 2003a Williams et al., , 2003b Acevedo et al., 2007) and sensorimotor gating in adulthood. The long-term cognitive effects of MA at a dose of 5 mg/kg are more severe in WT female than WT male mice, suggesting enhanced sensitivity to the neurotoxic effects of MA in females . This dose of MA also impairs hippocampal integrity in WT mice, as suggested by reductions in microtubule-associated protein-2 levels (Acevedo et al., 2008b) .
Importantly, peak levels of MA in the cortex and hippocampus do not differ between male and female WT mice following a 5 mg/kg dose of MA at postnatal day (PD) 20 (Acevedo et al., 2008b) . Therefore, in this study, we used the same dosing and injection paradigm as used in our earlier studies (Acevedo et al., , 2008b . We aimed to study the effects of MA during hippocampal development, but we recognize the limitations of comparing the exposure of mouse or rat pups with drugs of abuse during postnatal hippocampal development to inutero exposure of human fetuses during prenatal hippocampal development. In contrast, postnatal exposure does remove the potential confound of altered maternal care because of drug administration and withdrawal. Indeed, early life parental care can affect cognitive function later in life (Bredy et al., 2004; Rice et al., 2008) . Postnatal exposure to MA also controls potential variations in the dose of MA that each pup would receive in utero depending on the size of the litter. Finally, rats exposed to MA during postnatal development compared with in-utero exposure show altered nociception in adulthood, suggesting a unique effect of MA exposure during postnatal brain development (Hruba et al., 2010) .
Although there are consistent effects of MA exposure during brain development on cognition, there are individual differences in the degree of these impairments. For example, despite overall group differences between MAexposed and unexposed children on the Behavior Rating Inventory of Executive Function and a measure of spatial memory, some of the MA-exposed children were rated on the Behavior Rating Inventory of Executive Function and performed on the spatial memory task similar to the unexposed children . Individual differences in the degree of cognitive impairment after MA exposure suggest that other factors, such as genetic factors, may modulate the susceptibility to cognitive impairment after in-utero MA exposure. Given its role in neuronal repair after injury (Mahley, 1988; Arendt et al., 1997) , apolipoprotein E (apoE) may be one factor influencing the degree of brain damage resulting from in-utero MA exposure. ApoE plays a role in lipid transport and metabolism in the brain and exists as three major isoforms in humans: apoE2, apoE3, and apoE4 (Mahley, 1988) . ApoE modulates responses to CNS injury (Buttini et al., 1999; Lomnitski et al., 1999) and might also modulate susceptibility to cognitive impairments after exposure to MA during brain development. Compared with apoE3, apoE4 is associated with an increased risk of developing Alzheimer's disease (Saunders et al., 1993) and cognitive impairments after environmental challenges (Guangda et al., 1999; Crawford et al., 2002; Nathoo et al., 2003; Brichtova and Kozak, 2008) . Children carrying the e4 allele show impaired cognition compared with children without the e4 allele (Acevedo et al., 2009) . Mice lacking apoE show impaired acquisition of a test of attention (Siegel et al., 2009) and mice expressing apoE4 in neurons (Raber et al., 1998) or astrocytes (Van Meer et al., 2007) show impaired spatial learning and memory.
Little research has examined the effects of apoE in the context of drugs of abuse. However, studies do show that apoE4 is associated with increased cognitive impairments in alcoholic patients with Wernicke-Korsakoff syndrome (Muramatsu et al., 1997) and with smaller hippocampal volumes in female alcoholics (Bleich et al., 2003) . ApoE3 is associated with a history of alcohol withdrawal seizures compared with apoE2 (Wilhelm et al., 2007) . Furthermore, alcoholic patients carrying one e4 allele showed better visual memory than patients carrying one e2 allele (Bartres-Faz et al., 2002) . Mice lacking apoE show enhanced ethanol-conditioned place preference compared with WT mice, suggesting that apoE modulates the rewarding effects of ethanol in a mouse model (Bechtholt et al., 2004) . Thus, apoE modulates the way in which alcohol affects the brain and cognition. However, the effects of apoE on MA-induced brain and cognitive impairments have not yet been examined. As earlier studies in our laboratory have shown that MA exposure during hippocampal development alters adult cognitive function in WT mice , the goal of this study was to replicate this procedure in mice expressing human apoE isoforms to determine the potential ability of apoE to modulate the effects of MA on cognition.
MA exposure during brain development affects multiple neurotransmitter systems, including the dopamine and serotonin systems (Won et al., 1992 (Won et al., , 2002 Weissman and Caldecott-Hazard, 1993; Heller et al., 2001a Heller et al., , 2001b Crawford et al., 2003; Schaefer et al., 2007) . Although less known, MA also affects the brain acetylcholine (ACh) system. MA acutely increases ACh levels in adult mice (Dobbs and Mark, 2008) , alters ACh receptors in cell culture and adult rats (McCabe et al., 1987; Garcia-Rates et al., 2007) , and reduces choline acetyltransferase, the enzyme responsible for synthesizing ACh, in adult humans (Kish et al., 1999; Siegal et al., 2004) . There are two types of ACh receptors, nicotinic and muscarinic (Caulfield and Birdsall, 1998) , both of which are altered by MA (McCabe et al., 1987; Garcia-Rates et al., 2007) . The M 1 and M 2 muscarinic subtypes are expressed at high levels in the hippocampus and cortex, two areas of the brain important for cognitive function (Deacon et al., 2002; Alexander et al., 2007) . As the ACh system is involved in cognition (Van Hest et al., 1990; Muir et al., 1994; Voytko et al., 1994; Lin et al., 1998; Mirza and Stolerman, 2000) , potential MA-induced alterations in ACh receptors may contribute to the cognitive impairments observed after MA exposure during brain development.
The ACh system is also modulated by apoE. Mice lacking apoE show lower muscarinic ACh receptor (mAChR) binding in the cortex and hippocampus than WT mice (Siegel et al., 2009) , and apoE4 is associated with lower nucleus basalis neuronal activity (Salehi et al., 1998) and choline acetyltransferase activity than apoE2 and apoE3 (Poirier et al., 1995; Allen et al., 1997; Lai et al., 2006) . In this study, the effects of MA exposure during hippocampal development on cognition and ACh receptor binding in adulthood were assessed in male and female mice expressing apoE3 or apoE4.
Methods

Subjects
Human APOE targeted replacement mice expressing human apoE3 or apoE4 under the control of the mouse apoE promoter, on the C57BL/6J background (Sullivan et al., 1997; Knouff et al., 1999) , were provided by Dr Patrick Sullivan for breeding. Mice were housed and bred in our colony using homozygous mating. Laboratory chow (PicoLab Rodent Diet 20, #5053; PMI Nutrition International, St Louis, Missouri, USA) and water were freely available. Pups were weaned and group housed according to sex on PD 22. Litters were provided soft foods during the injection period and 2 weeks after weaning to maintain stable weight gain. The mice were kept on a 12 h light/dark schedule (lights on at 06:00 h). Behavioral testing took place during the light cycle. All procedures conformed to the standards of the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Animal Care and Use Committee of the Oregon Health and Science University.
Injections
(d)-MA hydrochloride (5 mg/kg), obtained from the Research Triangle Institute (Research Triangle Park, North Carolina, USA) through the National Institute on Drug Abuse drug supply program, was diluted with 0.9% sodium chloride (saline, SA) to the appropriate concentration. This dose was used based on earlier findings that it causes long-term cognitive impairments in WT mice exposed during hippocampal development . A total of 18 litters were used for this study: 10 apoE3 and eight apoE4 litters. Male and female pups were weighed and given a single intraperitoneal injection of 0.1 ml containing MA (n = 44) or SA (n = 40) daily at 10:00 h, from PD 11-21. A within-litter injection design was used to balance the number of MA and SA injections within a litter and across sexes.
Weight gain and maternal care
Owing to time and resource limitations, 11 of the 18 litters were chosen at random to be included in the weight gain and maternal care measures. The pups (n = 59; five apoE3 and six apoE4 litters) were weighed each day to measure weight gain over the injection period. These pups were individually labeled and video recorded from PD 8-21. One-hour video recordings were obtained at 1, 4, and 12-h postinjection time (10:00 h). Maternal nursing and grooming were scored every 4 min within each hour. For individual pups, one point was given if nursing or grooming was observed (Bredy et al., 2004) and the percent of maternal nursing and grooming out of the total possible observations was calculated and averaged across all days for each postinjection hour.
Behavioral testing
Litters born within a 2-week period were combined into cohorts for behavioral testing beginning on PD 90. Mice (n = 84) were singly housed 48 h before testing and all mice were tested consecutively using the following sequence of tests: novel location and novel object recognition, rotarod, prepulse inhibition (PPI), and the 5-choice serial reaction time task (5-SRTT). The tests are described in more detail below.
Novel location and novel object recognition
Mice were individually habituated to a lit open arena with clear Plexiglas walls (40.6 Â 40.6 cm; Hamilton-Kinder, Poway, California, USA) for 5 min for 3 consecutive days. On the fourth day, the mice were trained in five consecutive 10 min trials. The first three were familiarization trials with three objects placed within the arena (one in each of the three corners). For the novel location recognition test (fourth trial), one object was moved to a novel location in the arena. The same object was moved for all mice. For the novel object recognition test (fifth trial), one object was replaced with a novel object. The same object was replaced for all mice. A 4-min intertrial interval elapsed between all the trials. The time spent exploring each object during all trials was analyzed using a multiple body point video tracking system that can track the nose-point of a mouse [(Benice and Raber, 2008) , Ethovision XT, Noldus, Leesburg, Virginia, USA]. Exploration was counted when the nose was in a defined object zone 3 cm surrounding an object. The time spent exploring each object, as a percentage of the total exploration time, was calculated. The difference between the percent time spent exploring the object in the novel location (trial 4) and the percent time spent exploring the same object in its original location (trial 3) was calculated to measure novel location recognition. The percent time exploring the novel object as compared with the two familiar objects in trial 5 was calculated to measure novel object recognition. The arena was cleaned with 70% ethanol between trials to remove residual odors.
Rotarod
Sensorimotor function was assessed using a rotarod. The rod had a diameter of 7 cm and was placed 64 cm above the floor of a chamber (Hamilton-Kinder). The rod initially rotated at 5 rpm and accelerated by 5 rpm every 15 s. Mice were tested in three consecutive trials for 3 days. The average length of time on the rod (latency to fall) was measured. The rod was cleaned with 70% ethanol between trials to remove residual odors.
Prepulse inhibition
Mice were placed in an enclosure within a startle monitor sound-attenuated chamber and startle response amplitudes were measured with a force transducer (Hamilton-Kinder). Following a 5 min acclimation period, mice were exposed to 3, 40 ms acoustic stimuli (120 db). The testing phase consisted of 20 ms prepulses (70-80 db) followed by 50 ms delays and 40 ms acoustic stimuli (120 db). Random intertrial intervals were used between trials (15-30 s). PPI was calculated using the following formula: % response ¼ 100 Â ððS À PSÞ=SÞ, where S was the mean startle amplitude without a prepulse and PS was the mean startle response following a prepulse.
5-choice serial reaction time task
Operant learning and attention were assessed in the 5-SRTT. First, mice (n = 82) were food restricted to 80% of their free-feeding weight and tested in a 2-bottle preference test for sucrose solution as described earlier (Siegel et al., 2009) . Mice were tested for 20 min once a day in operant testing chambers [ (Robbins, 2002) , Med Associates, St Albans Vermont, USA]. Sucrose solution (5%, 20 ml) was used as the reward. 5-SRTT training and testing was performed as described earlier (Siegel et al., 2009) , with minor modifications. For training of the mice to retrieve a reward from the magazine (magazine training), the magazine light was illuminated and the reward was dispensed. Upon consumption, the magazine light was turned off and a 15 s intertrial interval elapsed. For training the mice to poke their nose in a hole to receive a reward (nosepoke training), all five holes in the chamber were illuminated and a nosepoke into any hole resulted in reward. After consumption and a 2 s intertrial interval, all the holes were reilluminated. For magazine and nosepoke training, mice were required to perform 40 responses for 2 consecutive days before advancing to the next level. Mice that failed to learn nosepoke training (more than 15 days without advancing) were returned to magazine training.
Level testing followed nosepoke training. For level testing, one of the five holes was illuminated and a nosepoke into the lit hole was rewarded. An incorrect nosepoke or failure to respond during the stimulus duration of the hole illumination (omission) resulted in a 5 s timeout (the house light was illuminated and the mice received no rewards). Mice progressed through levels 1, 2, 3, 4, 5, and 6 (20, 10, 8, 4, 2, and 1 s stimulus duration, respectively). Mice were required to perform at least 10 correct nosepoke responses at a maximum latency of half the stimulus duration for 2 consecutive days to advance to the next level. The number of days to pass a training level and the level at which a mouse failed to learn the task (more than 15 days without advancing) were measured. Mice that failed to learn a level were taken back to nosepoke training. Subsequent failure on any level resulted in removal from testing (dropout). At level 6, attention was measured by calculating the percent of correct responses and omissions before and during treatment with scopolamine, a general mAChR antagonist. Once asymptotic performance was reached (percent correct responses with 90-110% of average percent correct from previous 5 days), the mice were given a single intraperitoneal injection of SA or scopolamine (1.4, 0.8, or 0.2 mg/kg) each day before testing. All mice began with 3 consecutive days of SA injections, followed by 3 consecutive days of scopolamine (1.4 mg/kg), 3 days of SA, 3 days of scopolamine (0.8 mg/kg), 3 days of SA, and finally 3 days of scopolamine (0.2 mg/kg). If asymptotic performance was not reached after 55 days on level 6, mice with less than 15 total responses for more than 60% of the days or 115 days on level 6, whichever occurred first, were removed from testing (dropouts).
Muscarinic receptor binding
Receptor saturation binding experiments were performed following the 5-SRTT using cortical (n = 39) and hippocampal (n = 48) membrane preparations and radioligands specific for M 1 ([ 3 H]pirenzepine) or M 2 ([ 3 H]AF-DX-384) mAChRs (Watson et al., 1986; Vaucher et al., 2002; Siegel et al., 2009) . After behavioral testing, bilateral hippocampus and cortex were dissected and freshly frozen. Tissue preparations were homogenized in 1 ml of ice-cold buffer (140 mmol/l NaCl, 0.2 mmol/l KCl, 10 mmol/l MgCl 2 , 0.5 mmol/l EDTA, 50 mmol/l Tris, pH = 7.5), centrifuged at 16 000g for 25 min, washed in ice-cold buffer, and recentrifuged. The washing procedure was repeated four times and the membrane pellet was stored at -801C until use. Tissue pellets were resuspended in ice-cold binding buffer (10 mmol/l NaH 2 PO 4 , 10 mmol/l Na 2 HPO 4 , 1 mmol/l MgCl 2 , pH = 7.4) and protein concentrations were measured (BCA protein assay kit, Pierce, Rockford Illinois, USA).
Tissue samples (50 ml) were incubated for 1 h in triplicate (hippocampus) or duplicate (cortex) in a total volume of 200 ml, containing binding buffer (50 ml), radioligand (50 ml), and atropine or water (50 ml). For the cortical binding, eight different increasing concentrations of [ 3 H]pirenzepine (312.5 pmol/l-40 nmol/l) or [ 3 H]AF-DX-384 (390.6-50 nm) were used. Single point saturation binding was performed for hippocampal preparations due to a limited amount of tissue (64.0 nmol/l M 1 and 66.8 nmol/l M 2 ). To measure nonspecific binding, 2.5 mmol/l atropine was added. After incubation, 5 ml of ice-cold binding buffer was added and tissues were bound to filter paper (Beckman, Fullerton, California, USA) using a cell harvester (Brandel, Gaithersburg Maryland, USA). Filters were placed in tubes and 5 ml of scintillation fluid (Optiphase 2, Perkin Elmer, Waltham, Massachusetts, USA) was added before counting radioactivity using a b counter (LS 6000SC Beta counter, Beckman). The maximal number of binding sites (B max ) and the equilibrium dissociation constant (K d , for cortical binding only) were determined according to the Hill equation (Whiteaker et al., 2000) using nonlinear regression analysis and Graphpad Prism 4.0 software (Graphpad, San Diego, California, USA).
Data analysis
Analysis of variance (ANOVA) was used to assess the effects of treatment, genotype, and sex on weight gain, performance in the behavioral tests, and the B max and K d of the mAChRs in the hippocampus and cortex. Repeated-measures ANOVA was used to assess maternal care and the effects of scopolamine administration on performance in the 5-SRTT (repeated factors: postinjection hour and scopolamine dose). Low-bound estimates of epsilon were used for all repeated-measures ANOVA tests. Four mice were removed from the novel location recognition analysis because of influential outlier scores (greater than two standard deviations from the mean).
One cohort of mice (representing all genotypes, sexes, and treatments, n = 16) was removed from the novel object recognition analysis because of technical equipment problems during this phase of testing. The Kaplan-Meier method was used to assess the median training level at which mice were unable to learn the 5-SRTT (dropout level). The Fisher's exact test was conducted to assess dropout rates at each level of training in the 5-SRTT. Duncan's post-hoc tests were performed to compare groups where appropriate. Only significant interactions are reported. To examine the potential role of litter in mediating the effects of MA treatment, the outcome measures that showed a significant effect of MA treatment were reanalyzed with litter as the experimental unit. Data within the text are reported as mean ± SEM. All statistical tests were conducted with a two-tailed significance a level of 0.05.
Results
Weight gain and maternal care MA-injected and SA-injected pups were weighed each day during the injection period to monitor weight gain. MA-treated mice gained less weight than SA-treated mice [F(1,51) = 4.37, P < 0.05; Fig. 1 ]. In addition, apoE3 mice (1.90 ± 0.15 g) gained less weight than apoE4 mice [3.05 ± 0.10 g; F(1,51) = 43.03, P < 0.01]. There was no effect of sex on weight gain during the injection period.
As maternal care can influence behavior of the offspring in rodents (Bredy et al., 2004) , we measured maternal feeding and grooming to assess potential differences in the maternal care that MA-exposed and SA-exposed pups received during injections. During the baseline period (PD 8-10), there was no significant main effect of treatment, sex, or genotype on maternal feeding. Similarly, during the injection period (PD 11-21), there was no significant main effect of treatment, sex, or genotype on maternal feeding. However, there was a significant genotype Â postinjection hour interaction [F(1,51) = 5.16, P < 0.05]. ApoE3 mice received more maternal feeding than apoE4 mice at both 1 (apoE3: 66.37 ± 1.77, apoE4: 61.36 ± 1.65) and 4 h (apoE3: 70.06 ± 1.67, apoE4: 65.18 ± 1.35) postinjection (Table 1 describes significant effects for all outcome measures). There was no difference in maternal feeding between apoE3 and apoE4 mice at 12 h postinjection.
During the baseline period, there was no effect of treatment, sex, or genotype on maternal grooming. However, there was a significant genotype Â postinjection hour interaction [F(1,51) = 4.48, P < 0.05]. ApoE3 mice (3.73 ± 1.28) received more maternal grooming than apoE4 mice (0.82 ± 0.26) at 4 h post injection time before the start of injections (PD 8-10). There was no difference in baseline maternal grooming between apoE3 and apoE4 mice at 1 and 12 h postinjection time. There was no main effect of treatment, sex, or genotype on the percent of maternal grooming observations during the injection period (PD 11-21).
Novel location and novel object recognition
The percent time spent exploring an object in a novel versus familiar location was used as a measure of novel location recognition (Benice and Raber, 2008) . There was no significant main effect of treatment, sex, or genotype on the total amount of time spent exploring the objects over five trials (Fig. 2a ). There was also no significant main effect of treatment, sex, or genotype on novel location recognition. However, MA-treated female mice spent less time exploring the object in the new versus the old location than SA-treated female mice, as indicated by a significant sex Â treatment interaction [F(1,73) = 7.04, P = 0.01; Table 2 ]. Furthermore, paired t-tests collapsed across genotype for each group showed that MA-treated female mice did not show a significant difference in the percent time exploring the object in the new versus the old location ( Fig. 2b) , indicating impaired novel location recognition.
The percent time spent exploring a novel object was used as a measure of novel object recognition (Benice and Raber, 2008) . There was no significant main effect of treatment, sex, or genotype on the percent time spent exploring the novel object over the 10 min trial (Table 2) . Earlier studies suggest that the majority of object exploration occurs in the first few minutes of the novel object recognition test (Dix and Aggleton, 1999; Mumby et al., 2002) . Furthermore, the total time spent exploring 
Males Females
Weight gain from postnatal days 11-21 in mice injected with saline or methamphetamine collapsed across apolipoprotein E genotype. There was a main effect of treatment on weight gain, with saline-exposed mice gaining more weight over the injection period compared with methamphetamine-exposed mice. *P < 0.05 saline-treated mice higher than methamphetamine-treated mice. Data are expressed as mean + SEM.
the objects within each minute over the 10-min trial decreased in this study [repeated measures ANOVA; F(9,540) = 5.85, P < 0.01], suggesting that most of the exploration of the novel object occurred during the first part of the trial. Therefore, we also examined novel object recognition in the first 5 min of the 10-min trial. Over the first 5 min of the trial, MA-exposed mice spent significantly less time exploring the novel object than SA-exposed mice [F(1,60) = 4.48, P < 0.05; Table 2 ]. Furthermore, an ANOVA conducted with planned a priori contrasts between each of the objects, collapsed across genotype and sex, showed that SA-exposed mice spent more time exploring the novel object over the other two objects while MAexposed mice did not (Fig. 2c ). There was no significant effect of sex or genotype on novel object recognition.
Rotarod
As motor coordination can affect performance on cognitive tests, sensorimotor function was measured using the latency to fall in the rotarod test (Soderling et al., 2003) . There was no significant main effect of treatment, sex, or genotype on sensorimotor function in the rotarod test (Table 2) .
Prepulse inhibition
Sensorimotor gating was assessed using PPI. A 100% response in this test indicates complete inhibition of the startle response during prepulse trials. There was no significant main effect of treatment or sex on the baseline acoustic startle response or PPI. However, compared with apoE4 mice, apoE3 mice showed an increased baseline acoustic startle response to the 120 db stimulus [F(1,76) = 6.05, P < 0.02; Table 2 ] and increased PPI [F(1,76) = 7.38, P < 0.01; Table 2 ].
Attention behavior
All mice showed preference for a 5% sucrose solution over a 10 and 20% sucrose solution in a 2-bottle preference test [F(2,156) = 462.40, P < 0.001; data not shown]. Therefore, the 5% sucrose solution was used as the reward in the 5-SRTT. There was no significant main effect of treatment or genotype on the median dropout training level in the 5-SRTT (Kaplan-Meier analysis; P > 0.45 for both treatment and genotype, log-rank test). There was also no significant main effect of treatment or genotype on the dropout rates at each individual level of testing. The median dropout training level was lower among female than male mice (female median level, level 1: male median level, level 6: P < 0.01, log-rank test; Fig. 3a ). There was also a significant difference in dropout rates between male and female mice at level 1 (P < 0.001, Fisher's exact test). Female mice (53%) dropped out more than male mice (11%).
For the mice that remained in the 5-SRTT through level 6, there was no significant main effect of treatment, sex, or genotype on percent correct responses during level 6 testing before scopolamine injections. There was no significant main effect of treatment or sex on percent omissions during level 6 testing. However, before scopolamine injections, apoE3 mice showed more omissions than apoE4 mice [F(1,37) = 5.75, P < 0.02; Table 2 ].
Scopolamine-induced attention impairments
The effects of scopolamine, a general mAChR antagonist, on attention were assessed during level 6 of the 5-SRTT among the mice that did not dropout. All effects are mice of the same treatment, genotype, or sex compared to group listed. ApoE, apolipoprotein E; MA, methamphetamine; mAChR, muscarinic acetylcholine receptor; PPI, prepulse inhibition; SA, saline; 5-SRTT, 5-choice serial reaction time task.
P < 0.01; Fig. 3b ]. There was no significant main effect of treatment, sex, or genotype on percent correct responses. However, there was a significant treatment Â sex Â genotype interaction [F(1,16) = 4.82, P < 0.05]. Thus, the effects of sex and treatment were examined in each genotype. In apoE4 mice, there was no significant effect of sex or treatment on percent correct responses during the SA and scopolamine injections. In the apoE3 mice, there was a treatment Â sex interaction [F(1,6) = 9.23, P < 0.02]. When this interaction was explored further, there was no significant effect of treatment in female apoE3 mice, but there was a significant effect of treatment in the male mice. However, the group sizes at this point in the 5-SRTT were low (apoE3 SA male: n = 1; apoE3 MA male: n = 3), rendering this significant effect of treatment as uninterpretable.
Scopolamine treatment also affected percent omissions. For all mice, the percent omissions were higher during scopolamine (1.4 mg/kg) treatment than SA, scopolamine 0.8 mg/kg, and scopolamine (0.2 mg/kg) treatment [F(1,16) = 14.29, P < 0.01; Fig. 3c ). There was no significant main effect of treatment on percent omissions after the scopolamine or SA injections. There were more omissions in male mice (75.8 ± 3.1) than female mice [61.0 ± 4.3, F(1,16) = 16.41, P < 0.01] and in apoE3 mice (72.9 ± 3.6) than apoE4 mice [66.2 ± 4.3, F(1,16) = 9.20, P < 0.01]. Percent time exploring objects and preference to explore a familiar and novel object in a novel location novel object recognition test. (a) There was no effect of methamphetamine treatment, sex, or genotype on the total amount of time spent exploring the objects over the five testing trials. Data are collapsed across sex and apolipoprotein E genotype. (b) All groups except the methamphetamine-treated female mice explored the object more in the new location than the old location. Data are collapsed across apolipoprotein E genotype. *P < 0.05 percent time spent exploring the object in the new location was greater than the percent time spent exploring the object in the old location. (c) Saline-exposed mice explored the novel object more than the other two familiar objects while methamphetamine-exposed mice did not show this exploration preference for the novel object. Data are collapsed across sex and apolipoprotein E genotype. *P < 0.05 percent time spent exploring the novel object was greater than percent time exploring the other two familiar objects. Data are expressed as mean ± SEM.
Muscarinic receptor binding
In the hippocampus, there was no main effect of sex or genotype on the number (B max ) of M 1 mAChRs. However, MA-treated mice had more M 1 mAChRs (higher B max ) than SA-treated mice [F(1,16) = 11.24, P < 0.01; Fig. 4 ].
There was no significant main effect of treatment, sex, or genotype on the number of M 2 mAChRs in the hippocampus, although there was a trend for apoE4 mice to have more M 2 mAChRs than apoE3 mice [F(1,16) = 4.32, P = 0.054; Table 3 ). As the mice used for the binding studies were of different ages when they finished the 5-SRTT, we also analyzed the binding data using age and 5-SRTT dropout status as a covariate. When age or dropout status was included as covariates, the results for hippocampal binding remained unchanged.
There was no significant main effect of treatment, sex, or genotype on the number or affinity (K d ) of either M 1 or M 2 mAChRs in the cortex (Table 3) . When age or dropout status was included in the analyses as covariates, the results for cortical binding remained unchanged.
Litter analysis
To control for the potential effects of litter, we used litter as the experimental unit in the analyses where MA treatment showed a significant effect. Genotype was not included in these analyses, as there were no significant interactions between MA treatment and genotype. When litter was used as the experimental unit, there was no longer a significant effect of MA treatment on weight gain (Table 4 shows effects of litter analysis for all measures). For novel object recognition, the effect of sex became significant when litter was used as the experimental unit [F(1,41) = 5.46, P < 0.02], with male mice showing greater novel object recognition than female mice. The effect of MA treatment on novel object recognition remained significant. The effects of MA treatment and sex remained unchanged for novel location recognition and hippocampal M 1 mAChR B max when litter was used as the experimental unit (Table 4 ).
Discussion
Exposure to MA during brain development causes longterm cognitive impairments in humans and rodents (Struthers and Hansen, 1992; Vorhees et al., 2000 Vorhees et al., , 2007 Williams et al., 2002 Williams et al., , 2003a Williams et al., , 2003b Chang et al., 2004 Chang et al., , 2009 Acevedo et al., 2007 Acevedo et al., , 2008a . Consistent with these findings, here we show that mice expressing human apoE3 or apoE4 have long-term cognitive impairments after MA exposure during hippocampal development.
We also show that MA exposure during hippocampal development increases hippocampal M 1 mAChR levels in adulthood, supporting long-term effects of MA on the cholinergic system.
Similar to our findings in WT mice , both male and female MA-exposed mice showed deficits in novel object recognition, whereas only female MAexposed mice showed deficits in novel location recognition. This effect was independent of apoE isoform and supports an increased susceptibility of female mice to the effects of postnatal MA on performance of a hippocampus-dependent test (Save et al., 1992) . The mechanism underlying this increased susceptibility in female mice is not yet understood, although data suggest that female mice metabolize MA at a slower rate than male mice, potentially increasing the neurotoxicity of MA (Acevedo et al., 2008b) . Alternatively, male sex hormones may protect against MA-induced insults on brain development in mice. Androgens are protective against other brain challenges, such as b-amyloid toxicity (Pike, 2001) and apoE4 expression (Raber et al., 2002) . Future studies are warranted to determine the potential protective effect of androgens against the detrimental long-term effects of postnatal MA exposure.
The time period of MA exposure was designed to target both hippocampal and mAChR development (Aubert et al., 1996; Winzer-Serhan, 2008) . In the mouse brain, mAChRs increase during the first 3 postnatal weeks of life (Aubert et al., 1996) , the same period during which the hippocampus develops (Bayer et al., 1982; Altman and All measures shown as group means ± SEM. ApoE, apolipoprotein E; MA, methamphetamine; PPI, prepulse inhibition; SA, saline; SEM, standard error of mean; 5-SRTT, 5-choice serial reaction time task. *P < 0.05 main effect of genotype, apoE3 higher than apoE4 mice.
Long-term effects of methamphetamine exposure Siegel et al. 609 Bayer, 1990; Clancy et al., 2001 Clancy et al., , 2007a . Consistent with these mouse data, there is an increase in mAChRs and hippocampal development in the human fetal brain during the third trimester (Ravikumar and Sastry, 1985; Rice and Barone, 2000) . In children, in-utero MA exposure results in smaller hippocampal volumes (Chang et al., 2004) . In adult rodents, postnatal MA exposure results in altered expression of brain derived neurotrophic factor and nerve growth factor , decreased dendritic spine density (Williams et al., 2004) , and decreased microtubule-associated protein-2 levels (Acevedo et al., 2008b) in the hippocampus. These findings show the long-term effects of MA exposure on the hippocampus, a brain structure important for cognitive function (Save et al., 1992; Deacon et al., 2002) . The current results corroborate these findings and also suggest that postnatal MA exposure in mice causes long-term effects on the muscarinic receptor system. To the best of our knowledge, this is the first study to show long-term changes in the cholinergic system after MA exposure during brain development. These cholinergic changes might have important implications for MA-induced cognitive impairments. Therefore, future studies seem warranted to examine the potential effects of MA exposure on the cholinergic system at various ages and in multiple species.
The increase in hippocampal mAChRs in adulthood after postnatal MA exposure indicate that altered mAChR function might contribute to the long-term cognitive effects of MA exposure during brain development. Increases in hippocampal M 1 mAChRs may be a compensatory mechanism for other MA-induced cholinergic changes, such as decreases in ACh synthesis or release. mAChR changes and potential changes in other areas of the cholinergic system may be directly related to the MAinduced cognitive impairments. Novel object recognition is a cortex-dependent task (Bussey et al., 1999) and is disrupted by mAChR antagonism (Sambeth et al., 2007) . Although no changes in cortical mAChRs were found in this study, potential MA-induced alterations in ACh release or choline acetyltransferase levels may relate to impaired novel object recognition in MA-exposed mice. mAChR and other cholinergic changes in the hippocampus after MA exposure may relate to impaired novel location recognition in MA-exposed female mice. Novel location recognition is a hippocampus-dependent task (Save et al., 1992) and performance in mice is impaired by mAChR antagonism (Murai et al., 2007) . Although MAexposed male mice showed increased hippocampal M 1 mAChRs, they did not show novel location recognition impairments, suggesting that female mice may be more sensitive to the cognitive effects of altered cholinergic function than male mice. Indeed, adult female rats show greater decreases in hippocampal ACh levels after a cholinergic insult (Hortnagl et al., 1993 ) and show consistently lower levels of ACh release into the hippocampus (Masuda et al., 2005) compared with adult male rats. In contrast to adulthood, multiple studies suggest that male rodents are more sensitive to the long-term cognitive effects of neonatal cholinergic insult than female rodents (Van Hest et al., 1990; Arters et al., 1998; Timofeeva et al., 2008) . However, adolescent female rats show greater cognitive impairments after exposure to the cholinergic neurotoxin 192 IgG saporin on PDs 1 and 3 than male rats (Ricceri et al., 2002) , suggesting increased susceptibility of female rodents to cholinergic manipulations early in life under specific conditions.
Earlier studies from our laboratory show that postnatal MA exposure increases brain histamine (HA) levels in neonates (Acevedo et al., 2008b) and that increased HA might mediate the MA-induced cognitive impairments in adulthood, as blockade of HA activity blocked the longterm effects of postnatal MA . The cholinergic system is modulated by the histaminergic system [for a review, see Ref. (Bacciottini et al., 2001) ]. HA release from the tuberomammillary nucleus to the medial septum increases ACh release from the medial septum to the hippocampus (Bacciottini et al., 2001) . Thus, MA-induced increases in neonatal HA and potential subsequent increases in neonatal or adult ACh may lead to long-term changes in both the HA and ACh system, thus altering ACh receptor levels and cognitive performance in adulthood. Future studies are warranted to investigate other cholinergic alterations that occur in neonates and adults after postnatal MA exposure in mice and how these changes potentially relate to MA-induced cognitive impairments and the increased susceptibility of female mice to these impairments.
There was no effect of postnatal MA exposure on PPI or attention, as assessed in the 5-SRTT. Both these tasks are considered to be 'ACh dependent', as altered cholinergic function affects both PPI (Jones and Shannon, 2000; Ballmaier et al., 2002) and 5-SRTT performance (Gill et al., 2000; Mirza and Stolerman, 2000; Arnold et al., 2002) . The long-term cholinergic effects of postnatal MA exposure may not be sufficiently severe to cause impairments in PPI and 5-SRTT performance, but such impairments might be revealed at earlier time points after MA exposure. Alternatively, the lack of cholinergic receptor changes in other brain areas, such as the cortex, may leave sensorimotor gating and attention behavior intact in adulthood after postnatal MA exposure. Although not measured in this study, MA exposure during brain development has been shown to alter both dopaminergic (Heller et al., 2001a (Heller et al., , 2001b Crawford et al., 2003) and (Won et al., 1992 (Won et al., , 2002 Weissman and Caldecott-Hazard, 1993; Schaefer et al., 2007) function immediately after exposure and later in life in both cell cultures and rodents. As both of these neurotransmitters interact with the cholinergic system (Day and Fibiger, 1992; Gaykema and Zaborszky, 1996; Kenny et al., 2000; Bitner and Nikkel, 2002; Berlanga et al., 2005) , the effects of MA on cognition may be partially due to long-term changes in the dopamine and serotonin systems. Future studies are warranted to examine the interaction between these systems after exposure to MA during hippocampal development to understand potential mechanisms underlying MA-induced cognitive impairments.
In contrast to these findings, earlier studies in WT mice show impairments in PPI after postnatal MA exposure . Differences in PPI impairments might suggest a protective effect of human apoE against the effects of postnatal MA exposure on sensorimotor gating. This difference in behavioral impairments between WT and apoE3 or apoE4 mice may be a result of apoE functionality. ApoE is involved in the restoration of neuronal function and neurite outgrowth after brain injury [for a review, see Ref. (Raber, 2004) ]. Astrocytes synthesize apoE and secrete an apoE-cholesterol complex that circulates to injured regions within the brain where the cholesterol is used for membrane and synapse formation (Poirier, 1994) . Mouse apoE and human apoE may differ in trafficking and promotion of neurite outgrowth and species differences in ability of apoE to promote neurite outgrowth may account for differential brain repair and cognitive function following MA administration during brain development.
The lack of apoE effects in this study suggests that apoE does not influence effects of MA on the brain or behavior. However, it is important to keep in mind that only one aspect of the cholinergic system was investigated in this study and that apoE isoform may modulate the effects of MA on other aspects of the cholinergic system or on other neurotransmitter systems. Relatively few studies have examined how apoE genotype might interact with the effects of drugs of abuse, and those that have focus mainly on alcohol (Muramatsu et al., 1997; Bartres-Faz et al., 2002; Bleich et al., 2003; Bechtholt et al., 2004; Wilhelm et al., 2007) . Thus, these findings might contribute important information to the field of MA abuse and exposure. As the number of pregnant women using MA continues to increase (Terplan et al., 2009) , it is becoming more important to identify which factors influence the effects of MA on the brain and cognition in exposed children. These findings suggest that apoE genotype may not be a factor influencing differences in cognitive impairments observed in children after exposure to MA in utero .
Some limitations of this study should be noted. First and foremost, only 18 litters were used, and thus each pup was considered the experimental unit. Studies have found that litter effects on the outcome measures can be large and inflate the possibility of a type I error in statistical analyses (Holson and Pearce, 1992) . Owing to this limitation and based on the recommendations of Holson and Pearce (1992) , we reanalyzed all analyses in which MA showed an effect with litter as the experimental unit. We found that the only effect that changed was that of MA treatment on weight. However, this is likely because of the fact that genotype was consistent within a litter, and the apoE4 mice gained more weight over the injection period than the apoE3 mice. Weight gain may also depend on how much overall feeding the dam provided to the pups. The effect of MA treatment on novel location and novel object recognition, and the mAChR binding, remained significant when litter was used as the experimental unit.
In summary, the results from this study show that exposure to MA during a time period equivalent to the third trimester of human fetal gestation impaired novel location recognition in female mice and impaired novel object recognition in both male and female mice. MA exposure also altered cholinergic function by increasing hippocampal M 1 mAChR levels in adulthood. As the ACh system is important for cognitive function throughout life (Van Hest et al., 1990; Muir et al., 1994; Voytko et al., 1994; Lin et al., 1998; Mirza and Stolerman, 2000) , MA-induced ACh receptor alterations may contribute to the long-term cognitive impairments after MA exposure during brain development, especially in female mice. Future studies are warranted to examine the long-term effects of postnatal MA on other aspects of ACh function and their potential contribution to the long-term effects of postnatal MA on cognitive function.
